<DOC>
	<DOCNO>NCT02367222</DOCNO>
	<brief_summary>The purpose database study ass Arepanrix™ vaccination 2009 pandemic associate increased risk multiple sclerosis ( MS ) Manitoba , Canada .</brief_summary>
	<brief_title>A Database Study Estimate Risk Multiple Sclerosis Following Vaccination With Arepanrix™ Manitoba , Canada</brief_title>
	<detailed_description>This observational , retrospective , propensity-score match cohort study use Manitoba Immunization Monitoring System ( MIMS ) hospital , physician , prescription claim databases Manitoba Health ( MH ) Database System assess Arepanrix™ vaccination 2009 pandemic associate increased risk multiple sclerosis ( MS ) demyelinate condition ultimately lead multiple sclerosis diagnosis Manitoba , Canada . The data collect form follow link database : - Manitoba Health ( MH ) administrative database - Manitoba Immunization Monitoring System ( MIMS ) - Manitoba Health Population Registry ( MHPR ) - Drug Program Information Network ( DPIN ) - Hospital Abstract Database - The Medical Services database</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>The entire population Manitoba consider inclusion . Individuals less equal 6 month age ; Having le one year insurance coverage enrolment period ; Not register MH enrolment period ; Physician hospitalization record indicate diagnosis demyelinate condition 1971 ( early year information available ) index date .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>